Who We Are
Our Industry
Resources
COVID-19
Member Login
Covid-19
Recent Media
IFPMA Media Release: Three priorities to urgently increase access to COVID-19 vaccines
IFPMA Media Release: 11 billion COVID-19 vaccines produced in 2021 has resulted in the biggest immunization campaign in human history and 2022 will require more and better vaccine redistribution and innovation
Podcast: Eric Crampton Speaks to Graeme Jarvis About Covid-19 Medicines
IFPMA: Global Biopharma CEO/Top Executives COVID-19 Media Briefing – 7 September 2021
Airfinity: September 2021 Snap Shot COVID-19 Data - Vaccines and Therapeutics
Podcast: Eric Crampton and Graeme Jarvis on Intellectual Property Issues Around the COVID-19 Vaccines
Tool: Global Coronavirus COVID-19 Clinical Trial Tracker
Document: WHO DRAFT landscape of COVID-19 candidate vaccines – 3 November 2020
Document: Medicines New Zealand COVID-19 Master Database as at 11 June 2020
Document: WHO DRAFT landscape of COVID-19 candidate vaccines – 9 June 2020
Cracking COVID-19: Collaboration is Key says Medicines New Zealand
Increased likelihood of several suitable COVID-19 vaccines being developed
Document: Vaccines: Research and Development Cycle and Manufacturing Timelines
Biopharmaceutical sector waging war on COVID-19 with over 60 vaccines and medicines
COVID-19 Medicines
120
existing medicines in development
280
novel medicines in development
140
vaccines in development
